Recombinant Human Granzyme A Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 2905-SE
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Cys26-Val262, with a C-terminal 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >5,000 pmol/min/µg, as measured under the described conditions.
Formulation, Preparation and Storage
2905-SE
Formulation | Lyophilized from a 0.2 μm filtered solution in MES, NaCl and CaCl2 with Trehalose. |
Reconstitution | Reconstitute at 100 μg/mL in sterile 25 mM HEPES, 150 mM NaCl and 10 mM CaCl2, pH 7.5. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Granzyme A
Granzyme A is a member of the granzyme family of the serine proteases found specifically in the cytotoxic granules of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Granzyme A is the most abundant protease in CTL and NK cells. It induces caspase‑independent cell death when introduced into target cells by perforin (1). Human granzyme A is synthesized as a precursor (262 residues) with a signal peptide (residues 1‑26), a propeptide (residues 27-28) and a mature chain (residues 29-262 ) (2). The purified recombinant human Granzyme A consists of residues 26 to 262. After being activated by lysyl endopeptidase, it cleaves a thioester substrate as described in Activity Assay Protocol.
References
- Lieberman, J. and Z. Fan (2003) Curr. Opin. Immunol. 15:553.
- Gershenfeld, H.K. et al. (1988) Proc. Natl. Acad. Sci. USA 85:1184.
Alternate Names
Gene Symbol
UniProt
Additional Granzyme A Products
Product Documents for Recombinant Human Granzyme A Protein, CF
Product Specific Notices for Recombinant Human Granzyme A Protein, CF
For research use only